CAR T cell immunotherapy
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, March 31, 2015

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

Megan Harlan Fleischut and Kenneth Offit
Q & A
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, March 24, 2015

Women can use the results of genetic tests to make informed decisions about ovary removal to reduce cancer risk.

Exceptional responders of new drugs in clinical trials.
Decoder
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, March 24, 2015

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Pictured: Two doctors look at a computer screen showing a 3-D image of a patient.
In the Clinic
By Rosie Foster, MA  |  Tuesday, March 17, 2015

Allan Halpern (left) and Michael Marchetti review images assembled into a 3-D digital model of a patient.

Pictured: Charles Sawyers
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 12, 2015

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.

Surgeon Larissa Temple
Support
By Maureen Salamon, BA, Freelance Writer  |  Thursday, February 26, 2015

A new online survey aims to provide doctors with real-time information on their patients’ quality of life after rectal surgery.

Pictured: Michael Zelefsky
In the Clinic
By Eva Kiesler, PhD and Jim Stallard, MA
Monday, February 2, 2015

Researchers call for intensified efforts to help men with prostate cancer quit smoking after a recent MSK study revealed that patients who smoke during radiation therapy face a higher risk of both having the disease return and dying from it.

Epigenetics
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, January 30, 2015

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, January 28, 2015

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Pictured: Jaspreet Sandhu and Laura Leddy
Support
By Jennifer Castoro, BA, Managing/Copy Editor  |  Monday, January 26, 2015

Urinary problems like incontinence and overactive bladder can be an issue for cancer survivors. At MSK, our surgeons can offer a range of solutions.

Pictured: José Baselga
Video
By Memorial Sloan Kettering  |  Thursday, January 15, 2015

MSK Physician-in-Chief José Baselga discusses the amazing progress that has been made in fighting cancer.

Dentist Sae Hee Kim
Support
By Maureen Salamon, BA, Freelance Writer  |  Thursday, January 8, 2015

MSK dentist Sae Hee Kim discusses how cancer treatment can affect the teeth and gums and offers tips on how people with cancer can care for them.

Sandra D’Angelo and Jedd Wolchok
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Tuesday, January 6, 2015

A new treatment for advanced melanoma is the latest promising advance in immunotherapy tested in large part by our scientists.

Pictured: Peter Kingham
Perspective
By Peter Kingham, MD, Surgical Oncologist  |  Monday, December 15, 2014

Our top cancer specialists come together to consult on complex cases at weekly Disease Management Team meetings.

Pictured: Eytan Stein
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 11, 2014

An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

Center News

Stay Informed

Get the latest information about cancer care and research every month.